Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Page Path

HOME
ARTICLE CATEGORY
Review

Review

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Seong Kyun Na, Byung-Cheol Song

Clin Mol Hepatol. 2019;25(3):234-244. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0108

View: 8607 Download: 250 Web of Science: 21 Crossref: 23

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers

Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2019;25(3):223-233. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0107

View: 11111 Download: 419 Web of Science: 29 Crossref: 33

Unmet need in chronic hepatitis B management

Lilian Yan Liang, Grace Lai-Hung Wong

Clin Mol Hepatol. 2019;25(2):172-180. Published online February 12, 2019

DOI: https://doi.org/10.3350/cmh.2018.0106

View: 9907 Download: 400 Web of Science: 43 Crossref: 45

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 6204 Download: 182 Web of Science: 5 Crossref: 5

Advances in ultrasound diagnosis in chronic liver diseases

Hitoshi Maruyama, Naoya Kato

Clin Mol Hepatol. 2019;25(2):160-167. Published online February 18, 2019

DOI: https://doi.org/10.3350/cmh.2018.1013

View: 11658 Download: 481 Web of Science: 21 Crossref: 22

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2019;25(2):93-159. Published online June 12, 2019

DOI: https://doi.org/10.3350/cmh.2019.1002

View: 25614 Download: 653 Web of Science: 167 Crossref: 152

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti

Clin Mol Hepatol. 2019;25(1):30-36. Published online January 23, 2019

DOI: https://doi.org/10.3350/cmh.2018.0061

View: 8087 Download: 154 Web of Science: 14 Crossref: 17

Radiomics and radiogenomics of primary liver cancers

Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu

Clin Mol Hepatol. 2019;25(1):21-29. Published online November 16, 2018

DOI: https://doi.org/10.3350/cmh.2018.1007

View: 12915 Download: 420 Web of Science: 46 Crossref: 49

Pathologic differential diagnosis of metastatic carcinoma in the liver

Jeong Hwan Park, Jung Ho Kim

Clin Mol Hepatol. 2019;25(1):12-20. Published online October 5, 2018

DOI: https://doi.org/10.3350/cmh.2018.0067

View: 25810 Download: 1,127 Web of Science: 41 Crossref: 45

Recent research trends and updates on nonalcoholic fatty liver disease

Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn

Clin Mol Hepatol. 2019;25(1):1-11. Published online August 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0037

View: 19319 Download: 722 Web of Science: 70 Crossref: 66

Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story

Aiman Obed, Abdalla Bashir, Steffen Stern, Anwar Jarrad

Clin Mol Hepatol. 2018;24(4):358-366. Published online October 24, 2018

DOI: https://doi.org/10.3350/cmh.2018.0044

View: 10010 Download: 203 Web of Science: 3 Crossref: 6

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals

Soon Young Ko, Won Hyeok Choe

Clin Mol Hepatol. 2018;24(4):351-357. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0063

View: 10198 Download: 350 Web of Science: 4 Crossref: 1

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):278-293. Published online May 2, 2018

DOI: https://doi.org/10.3350/cmh.2018.1002

View: 10703 Download: 238 Web of Science: 13 Crossref: 12

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

Clin Mol Hepatol. 2018;24(3):230-277. Published online July 9, 2018

DOI: https://doi.org/10.3350/cmh.2018.1005

View: 30351 Download: 787 Web of Science: 42 Crossref: 45

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 15057 Download: 226 Web of Science: 20 Crossref: 27

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 14729 Download: 393 Web of Science: 37 Crossref: 41

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 13567 Download: 515 Web of Science: 39 Crossref: 40

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol. 2018;24(2):100-107. Published online December 22, 2017

DOI: https://doi.org/10.3350/cmh.2017.0067

View: 12286 Download: 532 Web of Science: 66 Crossref: 67

Epidemiology of alcoholic liver disease in Korea

Jae Young Jang, Dong Joon Kim

Clin Mol Hepatol. 2018;24(2):93-99. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0079

View: 12897 Download: 267 Web of Science: 22 Crossref: 20

Role of liver transplantation in severe alcoholic hepatitis

Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora

Clin Mol Hepatol. 2018;24(1):43-50. Published online January 10, 2018

DOI: https://doi.org/10.3350/cmh.2017.0027

View: 9784 Download: 179 Web of Science: 8 Crossref: 9

Prevention and management of gastroesophageal varices

Yeon Seok Seo

Clin Mol Hepatol. 2018;24(1):20-42. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0064

View: 22648 Download: 801 Web of Science: 61 Crossref: 70

Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea

Sook-Hyang Jeong

Clin Mol Hepatol. 2018;24(1):10-19. Published online January 5, 2018

DOI: https://doi.org/10.3350/cmh.2017.0066

View: 11392 Download: 289 Web of Science: 18 Crossref: 18

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 15529 Download: 495 Web of Science: 139 Crossref: 144

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 16480 Download: 550 Web of Science: 93 Crossref: 89

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

Dong Ho Lee

Clin Mol Hepatol. 2017;23(4):290-301. Published online October 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0042

View: 22072 Download: 491 Web of Science: 102 Crossref: 99

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol. 2017;23(4):280-289. Published online September 15, 2017

DOI: https://doi.org/10.3350/cmh.2017.0037

View: 16166 Download: 412 Web of Science: 91 Crossref: 94

Treatment options after sorafenib failure in patients with hepatocellular carcinoma

Imane El Dika, Ghassan K. Abou-Alfa

Clin Mol Hepatol. 2017;23(4):273-279. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0108

View: 9615 Download: 237 Web of Science: 29 Crossref: 29

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 11535 Download: 361 Web of Science: 38 Crossref: 36

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol. 2017;23(3):212-218. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0105

View: 8454 Download: 235 Web of Science: 17 Crossref: 19

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 13296 Download: 313 Web of Science: 85 Crossref: 85

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

14.0
First decision

07 Days

Publication after acceptance

03 Days

*Last 12 months

Viewed By 5165	MAFLD: How is it different from NAFLD?
Viewed By 4912	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4876	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4608	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4581	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 134	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach